Proliferating cell nuclear antigen pseudogene 4 (PCNAP4)

Proliferating cell nuclear antigen pseudogene 4 (PCNAP4) is categorized as a pseudogene and does not encode a functional protein product. There is no evidence in current databases or literature that it acts as a therapeutic target, receptor, enzyme, or partakes in any molecular pathways. The similar-sounding PCP4 (“Purkinje cell protein 4”) encodes a calmodulin-binding protein involved in calcium signaling and neuronal differentiation, but PCNAP4 should not be confused with PCP4[1][3][5]. The PCNAP4 name indicates it is a pseudogene derived from the Proliferating Cell Nuclear Antigen gene (PCNA), which is a genuine DNA replication and repair protein, but no functional or clinical data are available for PCNAP4 itself. No aliases, molecular functions, or disease associations for PCNAP4 were returned in standard genome, protein, or therapeutic target resources. Instead, existing results and known databases consistently point to "Purkinje cell protein 4 (PCP4)" as a valid gene and target, with calmodulin-binding activity, neuronal differentiation roles, and possible implications in cancer progression[1][3][5]. However, PCNAP4 and PCP4 are entirely separate entities. No interacting drugs, safety concerns, biomarkers, or mechanisms of action were identified for PCNAP4. Based on its “pseudogene” status and lack of functional protein, PCNAP4 is not a therapeutic target. Searching for information instead leads to results about "Purkinje cell protein 4," which is a distinct entity and should not be conflated with the pseudogene. If you intended to inquire about PCP4, refer to “Purkinje cell protein 4,” a valid protein-coding gene with substantial literature and known functions[1][3][5]. For PCNAP4, the absence of data and its categorization as a pseudogene indicates it is not an actionable molecular target.

Other names

PCNAP4